Beconase Aqueous Nasal Spray 200D

Beconase Aqueous Nasal Spray 200D


Beconase Aqueous Nasal Spray is indicated for the prophylaxis and treatment of perennial and seasonal allergic rhinitis including hayfever, and vasomotor rhinitis

Beconase Aqueous Nasal Spray 200D


Beconase Aqueous Nasal Spray is indicated for the prophylaxis and treatment of perennial and seasonal allergic rhinitis including hayfever, and vasomotor rhinitis.  Beclometasone dipropionate has a potent anti-inflammatory effect within the respiratory tract, with a lower incidence and severity of adverse events than those observed when corticosteroids are administered systemically

The recommended dosage is two sprays into each nostril twice daily (400 micrograms/day).  Once control has been established it may be possible to maintain control with fewer sprays.  A dosage regimen of one spray into each nostril morning and evening has been shown to be efficacious in some patients.  However, should symptoms recur, patients should revert to the recommended dosage of two sprays into each nostril morning and evening.  The minimum dose should be used at which effective control of symptoms is maintained.  Total daily administration should not normally exceed eight sprays.
For full therapeutic benefit regular usage is essential.  The co-operation of the patient should be sought to comply with the regular dosage schedule and it should be explained that maximum relief may not be obtained within the first few applications.
For children under six years old, there are insufficient clinical data to recommend use.

Beconase Aqueous Nasal Spray 200D
Beclometasone Dipropionate 50μg

There are no Reviews of this product.